cabozantinib
Showing 26 - 50 of 128
Advanced Adult Hepatocellular Carcinoma Trial in Chicago, Ann Arbor, Dallas (Cabozantinib)
Recruiting
- Advanced Adult Hepatocellular Carcinoma
- Cabozantinib
-
Chicago, Illinois
- +3 more
Aug 15, 2022
Metastatic Hormone Refractory Prostate Cancer Trial in Saint Louis (Cabozantinib, Nivolumab, Abiraterone acetate)
Recruiting
- Metastatic Hormone Refractory Prostate Cancer
- Cabozantinib
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 6, 2022
Bladder Cancer Trial in United States (Cabozantinib, Atezolizumab, Cystectomy)
Recruiting
- Bladder Cancer
- Cabozantinib
- +2 more
-
Hackensack, New Jersey
- +4 more
Aug 26, 2022
Refractory Cutaneous Melanoma Trial in Portland (Ipilimumab, Nivolumab, Cabozantinib)
Recruiting
- Refractory Cutaneous Melanoma
- Ipilimumab
- +2 more
-
Portland, OregonProvidence Portland Medical Center
Jun 8, 2022
Prostate Cancer Trial in Detroit, New York (Cabozantinib)
Recruiting
- Prostate Cancer
- Cabozantinib
-
Detroit, Michigan
- +2 more
Mar 30, 2022
Metastatic Urothelial Carcinoma, Bladder Cancer Trial in Tampa, Atlanta, Salt Lake City (Cabozantinib, Pembrolizumab)
Recruiting
- Metastatic Urothelial Carcinoma
- Bladder Cancer
- Cabozantinib
- Pembrolizumab
-
Tampa, Florida
- +2 more
Jun 9, 2022
Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Germany (Cabozantinib)
Recruiting
- Neuroendocrine Tumors
- Neuroendocrine Carcinoma
- Cabozantinib
-
Göttingen, Lower Saxony, Germany
- +5 more
Jun 27, 2022
Pancreatic Cancer Trial in Lexington (Cabozantinib, Pembrolizumab)
Recruiting
- Pancreatic Cancer
- Cabozantinib
- Pembrolizumab
-
Lexington, KentuckyUniversity of Kentucky Markey Cancer Center
Feb 26, 2022
d To Treat People With Renal Cell Carcinoma
Recruiting
- Renal Cell Carcinoma
- Cabozantinib
-
Tokyo, JapanTakeda Selected Site
Apr 26, 2022
Carcinoma Prostate Trial in Brescia (Cabozantinib)
Recruiting
- Carcinoma Prostate
- Cabozantinib
-
Brescia, ItalyAlfredo Berruti
Mar 2, 2022
Metastatic Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Philadelphia (Cabozantinib)
Recruiting
- Metastatic Renal Cell Carcinoma
- Clear-cell Metastatic Renal Cell Carcinoma
- Cabozantinib
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Mar 2, 2022
Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma
Active, not recruiting
- Renal Cell Carcinoma
- Cabozantinib
-
Padova, ItalyIstituto Oncologico Veneto
Feb 7, 2022
Prostate Cancer Trial in Houston (Cabozantinib, Androgen Ablation Therapy)
Completed
- Prostate Cancer
- Cabozantinib
- Androgen Ablation Therapy
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 23, 2022
Gastric Adenocarcinoma, GastroEsophageal Cancer Trial in Orange (Cabozantinib, Pembrolizumab)
Recruiting
- Gastric Adenocarcinoma
- GastroEsophageal Cancer
- Cabozantinib
- Pembrolizumab
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Apr 4, 2022
NF1, Neurofibromatosis, Plexiform Neurofibromas Trial in United States (Cabozantinib)
Active, not recruiting
- NF1
- +2 more
- Cabozantinib
-
Los Angeles, California
- +11 more
Jan 13, 2023
Head and Neck Squamous Cell Cancer, Recurrent Head and Neck Squamous Cell Cancer, Metastatic Head and Neck Squamous Cell Cancer
Active, not recruiting
- Head and Neck Squamous Cell Cancer
- +2 more
- Cabozantinib
- Cetuximab
-
Miami, Florida
- +8 more
Dec 2, 2022
Renal Cell Carcinoma Trial (Cabozantinib, Ipilimumab, Nivolumab)
Not yet recruiting
- Renal Cell Carcinoma
- Cabozantinib
- +4 more
- (no location specified)
Jun 9, 2022
Hepatocellular Carcinoma, HCC Trial in Orange (Nivolumab, Ipilimumab, Cabozantinib)
Recruiting
- Hepatocellular Carcinoma
- HCC
- Nivolumab
- +3 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Apr 4, 2022
Neuroendocrine Tumors Trial in Portland (Cabozantinib, Lu-177)
Not yet recruiting
- Neuroendocrine Tumors
- Cabozantinib
- Lu-177
-
Portland, OregonProvidence Portland Cancer Institute - Franz Clinic
Feb 10, 2022
Non Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer, Urothelial Carcinoma Trial in Augusta (Cabozantinib,
Recruiting
- Non Small Cell Lung Cancer
- +3 more
- Cabozantinib
- Pemetrexed
-
Augusta, GeorgiaAugusta University Georgia Cancer Center
Mar 6, 2022
Hepatocellular Carcinoma Trial in Dresden, Leipzig, Berlin (Cabozantinib)
Recruiting
- Hepatocellular Carcinoma
- Cabozantinib
-
Dresden, Saxonia, Germany
- +2 more
Mar 10, 2022
Breast Cancer Trial in Boston (Nivolumab, Cabozantinib)
Completed
- Breast Cancer
- Nivolumab
- Cabozantinib
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 29, 2021
Carcinoid Tumor, Carcinoid Tumor of GI System, Neuroendocrine Tumors Trial in Boston (Nivolumab, Cabozantinib)
Recruiting
- Carcinoid Tumor
- +2 more
- Nivolumab
- Cabozantinib
-
Boston, Massachusetts
- +1 more
Jan 14, 2022
High Grade Neuroendocrine Tumors Trial in Saint Louis (Cabozantinib, Blood for plasma biomarkers, Tissue biopsy)
Recruiting
- High Grade Neuroendocrine Neoplasms
- Cabozantinib
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 11, 2021
Advanced/Metastatic Cervical Cancer Trial in France (Cabozantinib)
Active, not recruiting
- Advanced/Metastatic Cervical Cancer
- Cabozantinib
-
Angers, France
- +7 more
Dec 29, 2021